Biosynthetic gene clusters with biotechnological applications in novel Antarctic isolates from Actinomycetota.

• Published in: Applied Microbiology and Biotechnology
• Main Authors: Bruna, Pablo, Núñez-Montero, Kattia, Contreras, María José, Leal, Karla, García, Matías, Abanto, Michel, Barrientos, Leticia
• Format: Article in Journal/Newspaper
• Language: English
• Published: Springer 2024
• Subjects: Micrococcaceae; Actinomycetota; Antarctic; Biosynthetic gene clusters; Secondary metabolites; Antarc*; Antarctica
• Online Access: https://doi.org/10.1007/s00253-024-13154-x; https://pubmed.ncbi.nlm.nih.gov/38717668; https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11078813/

Actinomycetota have been widely described as valuable sources for the acquisition of secondary metabolites. Most microbial metabolites are produced via metabolic pathways encoded by biosynthetic gene clusters (BGCs). Although many secondary metabolites are not essential for the survival of bacteria, they play an important role in their adaptation and interactions within microbial communities. This is how bacteria isolated from extreme environments such as Antarctica could facilitate the discovery of new BGCs with biotechnological potential. This study aimed to isolate rare Actinomycetota strains from Antarctic soil and sediment samples and identify their metabolic potential based on genome mining and exploration of biosynthetic gene clusters. To this end, the strains were sequenced using Illumina and Oxford Nanopore Technologies platforms. The assemblies were annotated and subjected to phylogenetic analysis. Finally, the BGCs present in each genome were identified using the antiSMASH tool, and the biosynthetic diversity of the Micrococcaceae family was evaluated. Taxonomic annotation revealed that seven strains were new and two were previously reported in the NCBI database. Additionally, BGCs encoding type III polyketide synthases (T3PKS), beta-lactones, siderophores, and non-ribosomal peptide synthetases (NRPS) have been identified, among others. In addition, the sequence similarity network showed a predominant type of BGCs in the family Micrococcaceae, and some genera were distinctly grouped. The BGCs identified in the isolated strains could be associated with applications such as antimicrobials, anticancer agents, and plant growth promoters, among others, positioning them as excellent candidates for future biotechnological applications and innovations. KEY POINTS: • Novel Antarctic rare Actinomycetota strains were isolated from soil and sediments • Genome-based taxonomic affiliation revealed seven potentially novel species • Genome mining showed metabolic potential for novel natural products.